secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001104659-25-120637
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

VYNE Therapeutics annual meeting elects directors, ratifies auditor, approves say-on-pay
--------------------------------------------------------------------------------

- Class I directors Elisabeth Sandoval Little and Steven Basta elected with ~3.9M votes each.
- Baker Tilly US, LLP ratified as independent auditor for FY 2024 with 15.3M votes for.
- Advisory vote on named executive officer compensation passed with 4.6M votes for.
- Quorum of 50.1% of 33.3M shares outstanding at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465925120637/0001104659-25-120637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465925120637/tm2533382d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-120637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer